Pharma Tech

FDA grants fast track status to Phanes’ spevatamig for advanced BTC

Aug 17, 2026, 8:42 AM

Read Full Article → FDA grants fast track status to Phanes’ spevatamig for advanced BTC

Translate article text

Choose a language and wait for the translated text.

Phanes Therapeutics has received fast track designation from the US FDA for spevatamig to treat patients with advanced and metastatic BTC.